Multidisciplinary Expert-Driven Consensus on the Evolving Treatment of Patients with Advanced Cutaneous Squamous Cell Carcinoma

Main Article Content

Michael R Migden
MD Anderson Cancer Center, Houston, TX

Todd E Schlesinger
Dermatology & Laser Center of Charleston, Charleston, SC

Chrysalyne D Schmults
Brigham and Women?s Hospital, Harvard Medical School, Boston,MA

Scott M Dinehart
Arkansas Skin Cancer Center, Little Rock, AR

Robert L Ferris
UPMC Hillman Cancer Center, Pittsburgh, PA

Morganna Freeman
City of Hope, Duarte, CA

Valerie Guild
AIM at Melanoma Foundation, Plano, TX

Shlomo Koyfman
Cleveland Clinic, Cleveland, OH

Anna C Pavlick
NYU Langone Health, New York City, NY

Gregory T Wolf
University of Michigan, Ann Arbor, MI

Guilherme Rabinowits
Miami Cancer Institute, FL

Neil Swanson
Oregon Health & Science University, Portland, OR

Keywords

squamous cell carcinoma, advanced, treatment

Abstract

Abstract not available.

References

1. Karia PS, et al. J Am Acad Dermatol 2013;68:957-966.

2. Rogers HW, et al. JAMA Dermatol 2015;151:1081-1086.

3. National Comprehensive Cancer Network. Squamous cell skin cancer (Version 2.2019). Accessed July 30, 2019.

4. Work G, et al. J Am Acad Dermatol 2018;78:560-578.

5. Arunachalam D, et al. Indian J Palliat Care 2011;17:184-190.

6. Berens AM, et al. Curr Opin Otolaryngol Head Neck Surg 2017;25:258-264.

7. Amin MB, et al. CA Cancer J Clin 2017;67:93-99. 8. Karia PS, et al. J Clin Oncol 2014;32:327-334.

Article Sidebar

Poster PDF
Published
Nov 9, 2019
DOI https://doi.org/10.25251/skin.3.supp.50

Article Details

How to Cite
[1]
Migden, M.R., Schlesinger, T.E., Schmults, C.D., Dinehart, S.M., Ferris, R.L., Freeman, M., Guild, V., Koyfman, S., Pavlick, A.C., Wolf, G.T., Rabinowits, G. and Swanson, N. 2019. Multidisciplinary Expert-Driven Consensus on the Evolving Treatment of Patients with Advanced Cutaneous Squamous Cell Carcinoma. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S50. DOI:https://doi.org/10.25251/skin.3.supp.50.
Issue
Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas
Section
Skin Cancer
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 > >>